Références Chapitre 14


  1. Clinical diagnosis and management of tuberculosis and measures for its prevention and control. London, UK: National Institute for Health and Clinical Excellence, 2006.

  2. Rouillon A, Perdrizet S, Parrot R. Transmission of tubercle bacilli: the effects of chemotherapy. Tubercle 1976; 57:275–299.

  3. Long, R et al. Relative versus absolute non contagiousness of respiratory tuberculosis on treatment. Infect Control Hosp Epidemiol 2003;24:831-838.

  4. Migliori, GB et al. Review of multi-drug resistant and extensively drug-resistant TB: global perspectives with a focus on sub-Saharan Africa. TMIH 2010; vol. 15, N° 09 PP 1052 – 1066.

  5. Organisation mondiale de la Santé. Politique de l'OMS pour la lutte contre la transmission de la tuberculose dans les établissements de santé, les structures collectives et les ménages, Genève. 2010.
    http://apps.who.int/iris/bitstream/10665/44429/1/9789242598322_fre.pdf

  6. Implementing the WHO policy on TB infection control. Tuberculosis Coalition for Technical Assistance.
    http://stoptb.org/wg/tb_hiv/assets/documents/TBICImplementationFramework1288971813.pdf

  7. Riley RL, Knight M, Middlebrook G. Ultraviolet susceptibility of BCG and virulent tubercle bacilli. Am Rev Respir Dis 1976;113:413–8.